Live feed
Filing
SC 13G/A
SC 13G/A0000902219-18-000062·ALNYLAM PHARMACEUTICALS, INC.
Schedule 13G ownership disclosure
ALNYLAM PHARMACEUTICALS INC COM
Security class unavailable · CUSIP: 02043Q107
Event date: 2017-12-29
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 9,182,530
- Percent of class
- 9.2600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902219-18-000062
- Form type
- SC 13G/A
- Filer
- ALNYLAM PHARMACEUTICALS, INC.
- CIK
- CIK 1178670
- Filed
- Feb 08, 2018
- Reporting period
- Dec 29, 2017
- Description
- Schedule 13G beneficial ownership